Exogenus Therapeutics and Lonza agreed to collaborate on the development of Exo-101, Exogenus’ exosome-based lead candidate. The company specializes in…
Scientific Pioneer Douglas Hanahan to Receive Prestigious Pezcoller Foundation-AACR International Award for Extraordinary Achievement in Cancer Research In a landmark…
Metabolic dysfunction-associated steatohepatitis (MASH) represents a complex and progressive liver disease, which often remains asymptomatic until advanced stages, posing considerable…